Anlon Healthcare Q2 FY27 Investor Presentation Highlights Strong Growth
Anlon Healthcare Ltd · Investor Presentation · 31 Oct 2026, 1:07 am
Anlon Healthcare Q2 FY27 Investor Presentation Highlights Strong Growth Anlon Healthcare reported consolidated Q2 FY27 revenue of ₹10,561.0 Lacs, up 102.3% YoY and 20.6% QoQ, with EBITDA rising 84.1% YoY to ₹2,524.1 Lacs (23.9% margin) and PAT surging 84.4% YoY to ₹1,717.8 Lacs (16.3% margin). H1 FY27 revenue reached ₹19,317.2 Lacs (+125.9% YoY) with PAT at ₹2,545.9 Lacs (+97.9% YoY). Growth is driven by core NSAID APIs, CDMO expansions (3 molecules), and recent acquisitions (Apiqo, Bizotic, Anlon Medicos), supported by ~1,200 MTPA upcoming capacity commissioning in Q1 FY28.
Original exchange filing (PDF)
More announcements from Anlon Healthcare Ltd
- We have attached herewith earning call transcript for the H1/Q2 FY-27. Kindly take the same on your record. Thank you. · 06 Nov 2026
- We have attached herewith link of Investor Call recording held on Tuesday, November 03, 2026. Kindly take the same on your record. Thank you. · 04 Nov 2026
- We have attached herewith Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. Kindly take the same on your record. Thank you. · 29 Oct 2026
- We have attached herewith outcome of Board Meeting held on Thursday, October 29, 2026. Kindly take the same on your record. Thank you. · 29 Oct 2026
- Anlon Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 29 Oct 2026
- We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you. · 29 Oct 2026
- We have attached herewith invitation for investor earning call. Kindly take the same on your record. Thank you. · 03 Nov 2026
- Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited Standalone and .... · 29 Oct 2026
